Biotech

All Articles

Lundbeck indications $2.5 B look for Longboard and also its epilepsy med

.After spying smash hit possibility in Longboard Pharmaceuticals' epilepsy med, mind disease-focused...

Lilly decides on UK for 1st Portal Laboratory in Europe

.Eli Lilly's Portal Labs is going global, with the U.K. government declaring today that the country ...

Jasper dials up dose after colonies feedbacks reoccur rapidly

.Jasper Therapy has mentioned comprehensive responses in 10 of the 12 persistent colonies people tha...

Transgene's popular cancer cells vaccination fails midphase test

.Transgene's curative vaccine prospect TG4001 has actually failed a stage 2 solid growth test. Howev...

Upstream swells IPO to $255M as it provides alongside CAMP4

.Upstream Bio has swollen its own IPO to $255 million as the provider signs up with CAMP4 Rehabs thi...

Sanofi fails MS research study, giving another blow to Denali deal

.Sanofi has actually quit a period 2 hardship of Denali Therapeutics-partnered oditrasertib in numer...

Turnstone gives up 60%, agitates C-suite to extend cash money

.Turnstone Biologics is actually lessening its own head count by 60% as well as agitating its own C-...

Gilead loses hope on $15M MASH wager after reviewing preclinical data

.In a year that has seen a confirmation and also a raft of readouts for metabolic dysfunction-associ...

Texas biotech axes cancer cells deal, pins really hopes on weight problems

.Alaunos Therapies is actually axing an arrangement with Precigen, losing hope licensing legal right...

Capricor portions even more records for DMD therapy after launching BLA

.Capricor Rehabs is taking a victory lap for their phase 2 Duchenne muscular dystrophy (DMD) test. A...